Essex Financial Services’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-1,160
Closed -$221K 305
2018
Q3
$221K Buy
+1,160
New +$213K 0.05% 262
2018
Q2
Sell
-1,870
Closed -$315K 359
2018
Q1
$315K Sell
1,870
-171
-8% -$28.7K 0.06% 258
2017
Q4
$334K Sell
2,041
-630
-24% -$113K 0.08% 199
2017
Q3
$547K Buy
2,671
+228
+9% +$53K 0.13% 142
2017
Q2
$594K Buy
2,443
+961
+65% +$226K 0.13% 169
2017
Q1
$354K Sell
1,482
-785
-35% -$183K 0.08% 228
2016
Q4
$476K Buy
2,267
+392
+21% +$81.2K 0.1% 183
2016
Q3
$430K Buy
1,875
+295
+19% +$72.1K 0.1% 185
2016
Q2
$365K Buy
1,580
+324
+26% +$74.7K 0.09% 216
2016
Q1
$337K Buy
1,256
+28
+2% +$8.02K 0.08% 221
2015
Q4
$384K Buy
1,228
+128
+12% +$38.1K 0.09% 207
2015
Q3
$299K Hold
1,100
0.08% 229
2015
Q2
$334K Hold
1,100
0.09% 224
2015
Q1
$327K Buy
+1,100
New +$314K 0.08% 225

Other funds holding AGN

Essex Financial Services's AGN Position: Q4 2018 in Review

Essex Financial Services sold out of Allergan plc (AGN) in Q4 2018, closing a stake of 1,160 shares — an estimated $221K sold.

Essex Financial Services first reported a position in AGN in Q1 2015 and held it in 14 quarters. The position peaked at $594K in Q2 2017. 1,007 funds tracked by Wall St. Rank hold AGN as of Q4 2018.

  • Essex Financial Services reported no remaining Allergan plc position as of Q4 2018 after selling out during the quarter.
  • Essex Financial Services sold 1,160 Allergan plc shares in Q4 2018, an estimated $221K.
  • Essex Financial Services first reported a position in Allergan plc in Q1 2015 and held it in 14 quarters.
  • Essex Financial Services's Allergan plc position peaked at $594K in Q2 2017.
  • 1,007 funds tracked by Wall St. Rank held Allergan plc as of Q4 2018.

Based on Essex Financial Services's 13F filing for Q4 2018, filed 7 Feb 2019.